John Oyler sold $31M of ONC
Chief Executive Officer at BeiGene, Ltd.. 100,000 shares at an average of $306.59, traded Dec 15, 2025, filed Dec 17, 2025.
Score components
- +25RoleCEO
- +25Trade size$30.7M at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +10.5%, 3m -7.8%, 6m -14.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001042047-25-000009, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -1,791 | $301.58 | $540k | 98,209 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -6,389 | $302.29 | $1.9M | 91,820 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -1,896 | $303.60 | $576k | 89,924 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -5,829 | $304.37 | $1.8M | 84,095 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -3,940 | $305.55 | $1.2M | 80,155 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -4,949 | $306.39 | $1.5M | 75,206 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -5,118 | $307.38 | $1.6M | 70,088 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -14,163 | $308.41 | $4.4M | 55,925 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -10,650 | $309.37 | $3.3M | 45,275 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -16,318 | $310.48 | $5.1M | 28,957 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -2,344 | $311.33 | $730k | 26,613 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -121 | $311.93 | $38k | 26,492 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -929 | $313.52 | $291k | 25,563 | Dec 17, 2025 |
| Dec 15, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -1,194 | $314.92 | $376k | 24,369 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -1,877 | $300.80 | $565k | 22,492 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -600 | $300.98 | $181k | 21,892 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -2,567 | $301.79 | $775k | 19,325 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -1,512 | $302.31 | $457k | 17,813 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -7,470 | $302.74 | $2.3M | 10,343 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -1,633 | $303.13 | $495k | 8,710 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -5,442 | $303.72 | $1.7M | 3,268 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -1,255 | $304.13 | $382k | 2,013 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -1,973 | $304.36 | $601k | 40 | Dec 17, 2025 |
| Dec 16, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -40 | $305.24 | $12k | 0 | Dec 17, 2025 |
Related signals
Other insiders at BeiGene, Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $418k 1,115 shares | -100% | |
| 33Weak | BeiGene, Ltd. | Xiaodong Wang director, other | $11M 31,028 shares | -100% | |
| 40Moderate | BeiGene, Ltd. | Xiaodong Wang director, other | $13M 38,287 shares | -527% | |
| 56Moderate | BeiGene, Ltd. | Titus B. Ball Principal Accounting Officer | $47k 132 shares | -100% | |
| 45Moderate | BeiGene, Ltd. | Xiaobin Wu President and COO | $106k 280 shares | -100% | |
| 39Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $960k 2,666 shares | -100% | |
| 65Notable | BeiGene, Ltd. | John Oyler Chief Executive Officer | $86M 240,810 shares | -100% | |
| 72Notable | BeiGene, Ltd. | Aaron Rosenberg Chief Financial Officer | $362k 1,157 shares | -100% | |
| 65Notable | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $338k 1,044 shares | -100% | |
| 34Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $542k 1,669 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.